These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12922944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of dofetilide and EGIS-7229, an antiarrhythmic agent possessing class III, IV, and IB activities, on myocardial refractoriness in hyperkalemia, hypokalemia, and during beta-adrenergic activation in the rabbit papillary muscle in vitro.
    Kovács A, Szénási G.
    J Pharmacol Sci; 2006 Apr; 100(4):303-9. PubMed ID: 16603803
    [Abstract] [Full Text] [Related]

  • 3. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
    Kovács A, Gyönös I, Magyar J, Bányász T, Nánási PP, Spedding M, Szénási G.
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
    Wirth KJ, Paehler T, Rosenstein B, Knobloch K, Maier T, Frenzel J, Brendel J, Busch AE, Bleich M.
    Cardiovasc Res; 2003 Nov 01; 60(2):298-306. PubMed ID: 14613859
    [Abstract] [Full Text] [Related]

  • 7. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
    Schreieck J, Wang Y, Gjini V, Korth M, Zrenner B, Schömig A, Schmitt C.
    J Cardiovasc Electrophysiol; 1997 Dec 01; 8(12):1420-30. PubMed ID: 9436780
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
    Martin CL, Palomo MA, Mcmahon EG.
    J Pharmacol Exp Ther; 1996 Jul 01; 278(1):154-62. PubMed ID: 8764346
    [Abstract] [Full Text] [Related]

  • 11. Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits.
    Huang ZJ, Dai DZ, Li N, Na T, Ji M, Dai Y.
    Clin Exp Pharmacol Physiol; 2007 Apr 01; 34(4):310-7. PubMed ID: 17324143
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499.
    Baskin EP, Lynch JJ.
    J Cardiovasc Pharmacol; 1994 Aug 01; 24(2):199-208. PubMed ID: 7526051
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017.
    Li HT, Wang YQ, Dai DZ, Kong RZ.
    Acta Pharmacol Sin; 2001 Jan 01; 22(1):32-6. PubMed ID: 11730558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of potassium channel blockers on changes in refractoriness of atrial cardiomyocytes induced by stretch.
    Qi J, Xiao J, Zhang Y, Li J, Liu Y, Li P, Liang L, Jiang B, Wen W, Zhao C, Liang D, Liu Y, Chen YH.
    Exp Biol Med (Maywood); 2009 Jul 01; 234(7):779-84. PubMed ID: 19429854
    [Abstract] [Full Text] [Related]

  • 20. Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.
    Kaumann AJ, Lemoine H.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct 01; 331(1):27-39. PubMed ID: 2866449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.